Patient-specific Predictors of Haemolysis with Percutaneous Ventricular Assist Devices.

ABSTRACT:

Introduction

Percutaneous ventricular assist devices (pVADs) are increasingly used in cardiogenic shock but are associated with complications including haemolysis. The aim of this study was to investigate patient characteristics associated with haemolysis in cardiogenic shock patient population.

Methods

Consecutive patients were identified using Current Procedural Terminology (CPT) codes for pVAD insertion. Patient characteristics, laboratory and imaging data, and patient outcomes were abstracted manually and using validated automated methods. Laboratory-defined haemolysis required a drop in haemoglobin ≥2 mg/dl with either lactate dehydrogenase ≥250 units/l or undetectable haptoglobin. Clinically significant haemolysis was defined as laboratory-defined haemolysis necessitat

SUBMITTER: Sullivan AE 

PROVIDER: S-EPMC11904419 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature